Skip to main content
SpringerLink
Log in

Hand Dermatitis: A Review of Clinical Features, Prevention and Treatment

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Hand dermatitis is a socially significant health problem. This review provides a discussion on the clinical features and patterns as well as the differential diagnosis of hand dermatitis, because these are essential for proper diagnosis in clinical practice. The morphology, however, is poorly related to the etiology in chronic cases. In all cases of chronic hand dermatitis, a full diagnostic examination should be undertaken and the etiology should be clarified and addressed in the treatment concept, instead of just moving directly from a morphological diagnosis to therapy. Preventive measures should be included in the treatment concept according to etiology. A stepwise approach for escalating therapy is advised, including basic topical therapy, topical corticosteroids, calcineurin inhibitors, as well as phototherapy and systemic therapy with corticosteroids, alitretinoin, cyclosporine, methotrexate, azathioprine, and others.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Diepgen TL, Agner T, Aberer W, Berth-Jones J, Cambazard F, Elsner P, et al. Management of chronic hand eczema. Contact Dermatitis. 2007;57(4):203–10. doi:10.1111/j.1600-0536.2007.01179.x.

    Article  PubMed  Google Scholar 

  2. Diepgen T, Elsner P, Schliemann S, Fartasch M, Köllner A, Skudlik C, et al. Management von Handekzemen Leitlinie ICD-10-Ziffer: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges. 2009;7(s3):s1–16.

    PubMed  Google Scholar 

  3. Bissonnette R, Diepgen TL, Elsner P, English J, Graham-Brown R, Homey B, et al. Redefining treatment options in chronic hand eczema (CHE). J Eur Acad Dermatol Venereol. 2010;24(Suppl 3):1–20. doi:10.1111/j.1468-3083.2010.03615.x.

    Article  PubMed  Google Scholar 

  4. Diepgen TL, Andersen KE, Chosidow O, Coenraads PJ, Elsner P, English J, et al. Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges. 2015;13(1):e1–22.

    Article  PubMed  Google Scholar 

  5. English J, Aldridge R, Gawkrodger DJ, Kownacki S, Statham B, White JM, et al. Consensus statement on the management of chronic hand eczema. Clin Exp Dermatol. 2009;34(7):761–9. doi:10.1111/j.1365-2230.2009.03649.x.

    Article  CAS  PubMed  Google Scholar 

  6. Menne T, Johansen JD, Sommerlund M, Veien NK, Danish Contact Dermatitis G. Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema. Contact Dermatitis. 2011;65(1):3–12. doi:10.1111/j.1600-0536.2011.01915.x.

    Article  PubMed  Google Scholar 

  7. Elsner P, Schliemann S. Pitfalls and errors in patch testing: suggestions for quality assurance. In: Lachapelle JM, editor. Patch testing tips. Berlin: Springer; 2014. p. 27–35.

    Chapter  Google Scholar 

  8. Scalone L, Cortesi PA, Mantovani LG, Belisari A, Ayala F, Fortina AB, et al. Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy. Br J Dermatol. 2015;172(1):187–95. doi:10.1111/bjd.13220.

    Article  CAS  PubMed  Google Scholar 

  9. Malten KE. Thoughts on irritant contact dermatitis. Contact Dermatitis. 1981;7(5):238–47.

    Article  CAS  PubMed  Google Scholar 

  10. Freeman S, Maibach H. Study of irritant contact dermatitis produced by repeat patch test with sodium lauryl sulfate and assessed by visual methods, transepidermal water loss, and laser Doppler velocimetry. J Am Acad Dermatol. 1988;19(3):496–502.

    Article  CAS  PubMed  Google Scholar 

  11. Ruppert L, Apfelbacher C, Molin S, Bauer A, Mahler V, Schmitt J, et al. Itching in patients with chronic hand eczema: data from the CARPE registry. Dermatology. 2014;229(2):146–53. doi:10.1159/000362901.

    Article  PubMed  Google Scholar 

  12. Johansen JD, Hald M, Andersen BL, Laurberg G, Danielsen A, Avnstorp C, et al. Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish Contact Dermatitis Group. Contact Dermatitis. 2011;65(1):13–21. doi:10.1111/j.1600-0536.2011.01911.x.

    Article  PubMed  Google Scholar 

  13. Diepgen TL, Andersen KE, Brandao FM, Bruze M, Bruynzeel DP, Frosch P, et al. Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol. 2009;160(2):353–8. doi:10.1111/j.1365-2133.2008.08907.x.

    Article  CAS  PubMed  Google Scholar 

  14. Molin S, Diepgen TL, Ruzicka T, Prinz JC. Diagnosing chronic hand eczema by an algorithm: a tool for classification in clinical practice. Clin Exp Dermatol. 2011;36(6):595–601. doi:10.1111/j.1365-2230.2010.04001.x.

    Article  CAS  PubMed  Google Scholar 

  15. Kutzner H, Wurzel RM, Wolff HH. Are acrosyringia involved in the pathogenesis of “dyshidrosis”? Am J Dermatopathol. 1986;8(2):109–16.

    Article  CAS  PubMed  Google Scholar 

  16. Lee WJ, Lee DW, Kim CH, Won CH, Chang SE, Lee MW, et al. Pompholyx with bile-coloured vesicles in a patient with jaundice: are sweat ducts involved in the development of pompholyx? J Eur Acad Dermatol Venereol. 2010;24(2):235–6. doi:10.1111/j.1468-3083.2009.03383.x.

    Article  CAS  PubMed  Google Scholar 

  17. Resnik KS, Kantor GR, Lessin SR, Kadin ME, Chooback L, Cooper HS, et al. Mycosis fungoides palmaris et plantaris. Arch Dermatol. 1995;131(9):1052–6.

    Article  CAS  PubMed  Google Scholar 

  18. Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004;18(4):397–415. doi:10.1111/j.1468-3083.2004.00937.x.

    Article  CAS  PubMed  Google Scholar 

  19. Wollina U. Pompholyx: what’s new? Expert Opin Investig Drugs. 2008;17(6):897–904. doi:10.1517/13543784.17.6.897.

    Article  CAS  PubMed  Google Scholar 

  20. Held E, Mygind K, Wolff C, Gyntelberg F, Agner T. Prevention of work related skin problems: an intervention study in wet work employees. Occup Environ Med. 2002;59(8):556–61.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Jungbauer FH, van der Harst JJ, Groothoff JW, Coenraads PJ. Skin protection in nursing work: promoting the use of gloves and hand alcohol. Contact Dermatitis. 2004;51(3):135–40.

    Article  CAS  PubMed  Google Scholar 

  22. Flyvholm MA, Mygind K, Sell L, Jensen A, Jepsen KF. A randomised controlled intervention study on prevention of work related skin problems among gut cleaners in swine slaughterhouses. Occup Environ Med. 2005;62(9):642–9. doi:10.1136/oem.2004.016576.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Weisshaar E, Radulescu M, Bock M, Albrecht U, Diepgen TL. Educational and dermatological aspects of secondary individual prevention in healthcare workers. Contact Dermatitis. 2006;54(5):254–60.

    Article  PubMed  Google Scholar 

  24. Seyfarth F, Schliemann S, Antonov D, Elsner P. Teaching interventions in contact dermatitis. Dermatitis. 2011;22(1):8–15.

    PubMed  Google Scholar 

  25. Slotosch CM, Kampf G, Loffler H. Effects of disinfectants and detergents on skin irritation. Contact Dermatitis. 2007;57(4):235–41. doi:10.1111/j.1600-0536.2007.01200.x.

    Article  CAS  PubMed  Google Scholar 

  26. Kappes UP, Goritz N, Wigger-Alberti W, Heinemann C, Elsner P. Tandem application of sodium lauryl sulfate and n-propanol does not lead to enhancement of cumulative skin irritation. Acta Derm Venereol. 2001;81(6):403–5.

    Article  CAS  PubMed  Google Scholar 

  27. Yokota M, Maibach HI. Moisturizer effect on irritant dermatitis: an overview. Contact Dermatitis. 2006;55(2):65–72. doi:10.1111/j.0105-1873.2006.00890.x.

    Article  PubMed  Google Scholar 

  28. Bourke J, Coulson I, English J. Guidelines for the management of contact dermatitis: an update. Br J Dermatol. 2009;160(5):946–54. doi:10.1111/j.1365-2133.2009.09106.x.

    Article  CAS  PubMed  Google Scholar 

  29. Kutting B, Baumeister T, Weistenhofer W, Pfahlberg A, Uter W, Drexler H. Effectiveness of skin protection measures in prevention of occupational hand eczema: results of a prospective randomized controlled trial over a follow-up period of 1 year. Br J Dermatol. 2009. doi:10.1111/j.1365-2133.2009.09485.x.

  30. Fartasch M, Diepgen TL, Drexler H, Elsner P, Fluhr JW, John SM, et al. Berufliche Hautmittel. 2008. http://www.awmf.org/uploads/tx_szleitlinien/013-056l_S1_Berufliche_Hautmittel_2008.pdf. Accessed 29 Nov 2014.

  31. Van Coevorden AM, Coenraads PJ, Svensson A, Bavinck JN, Diepgen TL, Naldi L, et al. Overview of studies of treatments for hand eczema-the EDEN hand eczema survey. Br J Dermatol. 2004;151(2):446–51. doi:10.1111/j.1365-2133.2004.06040.x.

    Article  PubMed  Google Scholar 

  32. De Paepe K, Hachem JP, Vanpee E, Goossens A, Germaux MA, Lachapelle JM, et al. Beneficial effects of a skin tolerance-tested moisturizing cream on the barrier function in experimentally-elicited irritant and allergic contact dermatitis. Contact Dermatitis. 2001;44(6):337–43 (cod440604 [pii]).

    Article  PubMed  Google Scholar 

  33. Ramsing DW, Agner T. Preventive and therapeutic effects of a moisturizer. An experimental study of human skin. Acta Derm Venereol. 1997;77(5):335–7.

    CAS  PubMed  Google Scholar 

  34. Loden M. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol. 2005;19(6):672–88. doi:10.1111/j.1468-3083.2005.01326.x (quiz 86–7).

    Article  CAS  PubMed  Google Scholar 

  35. Folster-Holst R, Latussek E. Synthetic tannins in dermatology—a therapeutic option in a variety of pediatric dermatoses. Pediatr Dermatol. 2007;24(3):296–301. doi:10.1111/j.1525-1470.2007.00406.x.

    Article  PubMed  Google Scholar 

  36. Nilsson E, Henning C, Hjorleifsson ML. Density of the microflora in hand eczema before and after topical treatment with a potent corticosteroid. J Am Acad Dermatol. 1986;15(2 Pt 1):192–7.

    Article  CAS  PubMed  Google Scholar 

  37. Frosch PJ, Schulze-Dirks A. Contact allergy caused by polidocanol (thesit). Hautarzt. 1989;40(3):146–9.

    CAS  PubMed  Google Scholar 

  38. Uter W, Geier J, Fuchs T. Contact allergy to polidocanol, 1992 to 1999. J Allergy Clin Immunol. 2000;106(6):1203–4 (S0091674900870852 [pii]).

    Article  CAS  PubMed  Google Scholar 

  39. Veenhuis RT, van Horssen J, Bos RP, Anzion RB, Van Der Valk PG. Highly increased urinary 1-hydroxypyrene excretion rate in patients with atopic dermatitis treated with topical coal tar. Arch Dermatol Res. 2002;294(4):168–71. doi:10.1007/s00403-002-0311-5.

    Article  CAS  PubMed  Google Scholar 

  40. Luger T, Loske KD, Elsner P, Kapp A, Kerscher M, Korting HC, et al. Topical skin therapy with glucocorticoids–therapeutic index. J Dtsch Dermatol Ges. 2004;2(7):629–34.

    Article  PubMed  Google Scholar 

  41. Luger T, Elsner P, Kerscher M, Korting HC, Krutmann J, Niedner R, et al. Topische Dermatotherapie mit Glukokortikoiden—Therapeutischer Index. ICD 10: L20. In: Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG). Düsseldorf. 2009. http://www.derma.de/fileadmin/derma/pdfs/ll_glukokortikoide.pdf. Accessed 29 Nov 2014.

  42. Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol. 1999;140(5):882–6 (bjd2819 [pii]).

    Article  CAS  PubMed  Google Scholar 

  43. Hachem JP, De Paepe K, Vanpee E, Kaufman L, Rogiers V, Roseeuw D. Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements. Dermatology. 2001;202(4):314–9 (drm02314 [pii]).

    Article  CAS  PubMed  Google Scholar 

  44. Corticosteroids Isaksson M. Dermatol Ther. 2004;17(4):314–20. doi:10.1111/j.1396-0296.2004.04036.x.

    Article  Google Scholar 

  45. Isaksson M, Bruze M. Repetitive usage testing with budesonide in experimental nickel–allergic contact dermatitis in individuals hypersensitive to budesonide. Br J Dermatol. 2001;145(1):38–44 (bjd4279 [pii]).

    Article  CAS  PubMed  Google Scholar 

  46. Uter W, de Padua CM, Pfahlberg A, Nink K, Schnuch A, Lessmann H. Contact allergy to topical corticosteroids–results from the IVDK and epidemiological risk assessment. J Dtsch Dermatol Ges. 2009;7(1):34–41, 34–42. doi:10.1111/j.1610-0387.2008.06844.x.

  47. Luger T, Paul C. Potential new indications of topical calcineurin inhibitors. Dermatology. 2007;215(Suppl 1):45–54. doi:10.1159/000102119.

    Article  CAS  PubMed  Google Scholar 

  48. Schliemann S, Kelterer D, Bauer A, John SM, Skudlik C, Schindera I, et al. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Dermatitis. 2008;58(5):299–306. doi:10.1111/j.1600-0536.2007.01314.x.

    Article  CAS  PubMed  Google Scholar 

  49. Queille-Roussel C, Graeber M, Thurston M, Lachapelle JM, Decroix J, de Cuyper C, et al. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. Contact Dermatitis. 2000;42(6):349–50.

    Article  CAS  PubMed  Google Scholar 

  50. Thelmo MC, Lang W, Brooke E, Osborne BE, McCarty MA, Jorizzo JL, et al. An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. J Dermatol Treat. 2003;14(3):136–40 (ECGNGAJB45URRKDW [pii]).

    Article  CAS  Google Scholar 

  51. Ring J, Barker J, Behrendt H, Braathen L, Darsow U, Dubertret L, et al. Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol. 2005;19(6):663–71. doi:10.1111/j.1468-3083.2005.01315.x.

    Article  CAS  PubMed  Google Scholar 

  52. Belsito DV, Fowler JF Jr, Marks JG Jr, Pariser DM, Hanifin J, Duarte IA, et al. Pimecrolimus cream 1 %: a potential new treatment for chronic hand dermatitis. Cutis. 2004;73(1):31–8.

    PubMed  Google Scholar 

  53. Margolis DJ, Abuabara K, Hoffstad OJ, Wan J, Raimondo D, Bilker WB. Association between malignancy and topical use of pimecrolimus. JAMA Dermatol. 2015. doi:10.1001/jamadermatol.2014.4305.

  54. Wollenberg A, Frank R, Kroth J, Ruzicka T. Proactive therapy of atopic eczema–an evidence-based concept with a behavioral background. J Dtsch Dermatol Ges. 2009;7(2):117–21. doi:10.1111/j.1610-0387.2008.06772.x.

    PubMed  Google Scholar 

  55. Bauer A, Lange N, Matterne U, Meurer M, Braeutigam M, Diepgen TL. Efficacy of pimecrolimus 1 % cream in the long term management of atopic hand dermatitis. A double-blind RCT. J Dtsch Dermatol Ges. 2012;10(6):426–33. doi:10.1111/j.1610-0387.2011.07832.x.

    PubMed  Google Scholar 

  56. Brasch J, Becker D, Aberer W, Bircher A, Kranke B, Denzer-Furst S, et al. Contact dermatitis. J Dtsch Dermatol Ges. 2007;5(10):943–51. doi:10.1111/j.1610-0387.2007.06523.x.

    Article  PubMed  Google Scholar 

  57. Jensen L, Stensgaard A, Andersen KE. Psoralen plus ultraviolet A (PUVA) soaks and UVB TL01 treatment for chronic hand dermatoses. Dermatol Rep. 2012;4(1):e3. doi:10.4081/dr.2012.e3.

    Article  Google Scholar 

  58. Hölzle E, Gollnick H, Herzinger T, Hönigsmann H, Lehmann P, Meffert H, et al. Empfehlungen zur Phototherapie und Photochemotherapie. 2002. http://www.awmf.org/uploads/tx_szleitlinien/013-029-abgelaufen.pdf. Accessed 29 Nov 2014.

  59. Schempp CM, Muller H, Czech W, Schopf E, Simon JC. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol. 1997;36(5 Pt 1):733–7 (S0190-9622(97)80326-X [pii]).

    Article  CAS  PubMed  Google Scholar 

  60. Behrens S, von Kobyletzki G, Gruss C, Reuther T, Altmeyer P, Kerscher M. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed. 1999;15(2):47–51.

    Article  CAS  PubMed  Google Scholar 

  61. Stege H, Berneburg M, Ruzicka T, Krutmann J. Cream PUVA photochemotherapy. Hautarzt. 1997;48(2):89–93.

    Article  CAS  PubMed  Google Scholar 

  62. Polderman MC, Govaert JC, le Cessie S, Pavel S. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol. 2003;28(6):584–7 (1378 [pii]).

    Article  CAS  PubMed  Google Scholar 

  63. Petering H, Breuer C, Herbst R, Kapp A, Werfel T. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol. 2004;50(1):68–72. doi:10.1016/S0190.

    Article  PubMed  Google Scholar 

  64. Schmidt T, Abeck D, Boeck K, Mempel M, Ring J. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol. 1998;78(4):318–9.

    Article  CAS  PubMed  Google Scholar 

  65. Stege H. Ultraviolet therapy in patients with chronic hand eczema. Hautarzt. 2008;59(9):696–702. doi:10.1007/s00105-008-1558-3.

    Article  CAS  PubMed  Google Scholar 

  66. van Coevorden AM, Kamphof WG, van Sonderen E, Bruynzeel DP, Coenraads PJ. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. Arch Dermatol. 2004;140(12):1463–6. doi:10.1001/archderm.140.12.1463.

    PubMed  Google Scholar 

  67. Bayerl C, Gabea A, Peiler D, Rzany B, Allgäuer T, Kleesz P, et al. Pilotstudie zur Therapie des beruflich bedingten Handekzems mit einer neuen tragbaren UVB-Bestralungseinheit. Aktuelle Derm. 1999;25:302–5.

    Google Scholar 

  68. Fairris GM, Jones DH, Mack DP, Rowell NR. Superficial X-ray therapy in the treatment of constitutional eczema of the feet. Br J Dermatol. 1984;111(4):500–2.

    Article  CAS  PubMed  Google Scholar 

  69. Lofgren SM, Warshaw EM. Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis. 2006;17(4):165–81.

    Article  PubMed  Google Scholar 

  70. NICE. Grenz rays therapy for inflammatory skin conditions. 2007. http://guidance.nice.org.uk/IPG236. Accessed 29 Nov 2014.

  71. Warner JA, Cruz PD Jr. Grenz ray therapy in the new millennium: still a valid treatment option? Dermatitis. 2008;19(2):73–80.

    PubMed  Google Scholar 

  72. Fairris GM, Jones DH, Mack DP, Rowell NR. Conventional superficial X-ray versus Grenz ray therapy in the treatment of constitutional eczema of the hands. Br J Dermatol. 1985;112(3):339–41.

    Article  CAS  PubMed  Google Scholar 

  73. Bollag W, Ott F. Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid. Dermatology. 1999;199(4):308–12 (drm99308 [pii]).

    Article  CAS  PubMed  Google Scholar 

  74. Cheng C, Michaels J, Scheinfeld N. Alitretinoin: a comprehensive review. Expert Opin Investig Drugs. 2008;17(3):437–43. doi:10.1517/13543784.17.3.437.

    Article  CAS  PubMed  Google Scholar 

  75. Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008;158(4):808–17. doi:10.1111/j.1365-2133.2008.08487.x.

    Article  CAS  PubMed  Google Scholar 

  76. Reymann F. Two years’ experience with Tigason treatment of pustulosis palmo-plantaris and eczema keratoticum manuum. Dermatologica. 1982;164(3):209–16.

    Article  CAS  PubMed  Google Scholar 

  77. Hanifin JM, Stevens V, Sheth P, Breneman D. Novel treatment of chronic severe hand dermatitis with bexarotene gel. Br J Dermatol. 2004;150(3):545–53. doi:10.1046/j.1365-2133.2003.05729.x.

    Article  CAS  PubMed  Google Scholar 

  78. Thestrup-Pedersen K, Andersen KE, Menne T, Veien NK. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol. 2001;81(5):353–5.

    Article  CAS  PubMed  Google Scholar 

  79. Reitamo S, Granlund H. Cyclosporin A in the treatment of chronic dermatitis of the hands. Br J Dermatol. 1994;130(1):75–8.

    Article  CAS  PubMed  Google Scholar 

  80. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996;76(5):371–6.

    CAS  PubMed  Google Scholar 

  81. Mrowietz U, Eberhard Klein C, Reich K, Rosenbach T, Ruzicka T, Sebastian M, et al. Therapie mit Ciclosporin in der Dermatologie. 2000. http://www.derma.de/fileadmin/derma/pdfs/ll_ciclosporin.pdf. Accessed 29 Nov 2014.

  82. Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema—a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007;21(5):606–19. doi:10.1111/j.1468-3083.2006.02023.x.

    CAS  PubMed  Google Scholar 

  83. Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet. 2001;358(9287):1042–5. doi:10.1016/S0140-6736(01)06179-7.

    Article  CAS  PubMed  Google Scholar 

  84. Vakeva L, Reitamo S, Pukkala E, Sarna S, Ranki A. Long-term follow-up of cancer risk in patients treated with short-term cyclosporine. Acta Derm Venereol. 2008;88(2):117–20. doi:10.2340/00015555-0360.

    Article  CAS  PubMed  Google Scholar 

  85. Verma KK, Mahesh R, Srivastava P, Ramam M, Mukhopadhyaya AK. Azathioprine versus betamethasone for the treatment of parthenium dermatitis: a randomized controlled study. Indian J Dermatol Venereol Leprol. 2008;74(5):453–7.

    Article  PubMed  Google Scholar 

  86. Verma KK, Bansal A, Sethuraman G. Parthenium dermatitis treated with azathioprine weekly pulse doses. Indian J Dermatol Venereol Leprol. 2006;72(1):24–7.

    Article  PubMed  Google Scholar 

  87. Wise M, Callen JP. Azathioprine: a guide for the management of dermatology patients. Dermatol Ther. 2007;20(4):206–15. doi:10.1111/j.1529-8019.2007.00134.x.

    Article  PubMed  Google Scholar 

  88. Anstey AV, Wakelin S, Reynolds NJ. Guidelines for prescribing azathioprine in dermatology. Br J Dermatol. 2004;151(6):1123–32. doi:10.1111/j.1365-2133.2004.06323.x.

    Article  CAS  PubMed  Google Scholar 

  89. Egan CA, Rallis TM, Meadows KP, Krueger GG. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol. 1999;40(4):612–4 (S0190-9622(99)70446-9 [pii]).

    Article  CAS  PubMed  Google Scholar 

  90. Shaffrali FC, Colver GB, Messenger AG, Gawkrodger DJ. Experience with low-dose methotrexate for the treatment of eczema in the elderly. J Am Acad Dermatol. 2003;48(3):417–9. doi:10.1067/mjd.2003.137.

    Article  PubMed  Google Scholar 

  91. Pickenacker A, Luger TA, Schwarz T. Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol. 1998;134(3):378–9.

    Article  CAS  PubMed  Google Scholar 

  92. Bagot M, Terki N, Bacha S, Moyse D, Suck C, Revuz J. Per os desensitization in nickel contact eczema: a double-blind placebo-controlled clinico-biological study. Ann Dermatol Venereol. 1999;126(6–7):502–4 (MDOI-AD-06-1999-126-6-7-0151-9638-101019-ART4 [pii]).

    CAS  PubMed  Google Scholar 

  93. Handa S, Sahoo B, Sharma VK. Oral hyposensitization in patients with contact dermatitis from Parthenium hysterophorus. Contact Dermatitis. 2001;44(5):279–82 (cod440505 [pii]).

    Article  CAS  PubMed  Google Scholar 

  94. Sharma AD. Relationship between nickel allergy and diet. Indian J Dermatol Venereol Leprol. 2007;73(5):307–12.

    Article  PubMed  Google Scholar 

  95. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–72.

    Article  PubMed  Google Scholar 

  96. Weisshaar E, Kallen U, Weiss M. “The itching hand”—important differential diagnoses and treatment. J Dtsch Dermatol Ges. 2013;11(1):31–42. doi:10.1111/j.1610-0387.2012.08002.x.

    PubMed  Google Scholar 

Download references

Disclosures

Funding—no funding was provided for the completion of this article.

Conflict of interest

P. Elsner declared having received speaker fees from the following pharmaceutical companies: Galderma, Astellas, GSK, Jenapharm, Leo, L’Oreal, Meda, Novartis, Pierre Fabre. S. Schliemann declared having received speaker fees from Novartis. D. Antonov declared no conflict of interest. The above-mentioned fees were received as payments for scientific lectures fulfilling the criteria of liberty and independence of science according to section 5(3) of the German constitution, thus not impairing the scientific independence of the speaker.

Author information

Authors and Affiliations

  1. Department of Dermatology, University Hospital Jena, Erfurter Str. 35, 07743, Jena, Germany

    Dimitar Antonov, Sibylle Schliemann & Peter Elsner

Authors
  1. Dimitar Antonov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sibylle Schliemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Elsner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Elsner.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antonov, D., Schliemann, S. & Elsner, P. Hand Dermatitis: A Review of Clinical Features, Prevention and Treatment. Am J Clin Dermatol 16, 257–270 (2015). https://doi.org/10.1007/s40257-015-0130-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-015-0130-z

Keywords

Search

Navigation